EUVIMEDEUVIMED entdecken
Open Access

Humoral Correlates of Protection Against Influenza A/H3N2 Virus Infection

Gregory Hoy iD, Daniel Stadlbauer, Angel Balmaseda, Guillermina Kuan, Roger López, Juan Manuel Carreno Quiroz, Sergio Ojeda, Nery Sánchez, Temima Yellin, Miguel Plazaola, Aaron Frutos, Florian Krammer iD und 1 weitere

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiae258 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Gregory Hoy und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, University of Michigan, Ann Arbor. Hauptthemen laut MEDLINE: Influenza, Human, Influenza A Virus, H3N2 Subtype, Antibodies, Viral, Hemagglutination Inhibition Tests. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Allergy and Infectious Diseases, NIAID NIH HHS, University of Michigan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Influenza virus remains a threat to human health, but gaps remain in our knowledge of the humoral correlates of protection against influenza virus A/H3N2, limiting our ability to generate effective, broadly protective vaccines. The role of antibodies against the hemagglutinin (HA) stalk, a highly conserved but immunologically subdominant region, has not been established for influenza virus A/H3N2.

Methods

Household transmission studies were conducted in Managua, Nicaragua, across 3 influenza seasons. Household contacts were tested for influenza virus infection using reverse-transcription polymerase chain reaction. We compared preexisting antibody levels against full-length HA, HA stalk, and neuraminidase (NA) measured by enzyme-linked immunosorbent assay, along with hemagglutination inhibition assay titers, between infected and uninfected participants.

Results

A total of 899 individuals participated in household activation, with 329 infections occurring. A 4-fold increase in initial HA stalk titers was independently associated with an 18% decrease in the risk of infection (adjusted odds ratio [aOR], 0.82 [95% confidence interval {CI}, .68–.98]; P = .04). In adults, anti-HA stalk antibodies were independently associated with protection (aOR, 0.72 [95% CI, .54–.95]; P = .02). However, in 0- to 14-year-olds, anti-NA antibodies (aOR, 0.67 [95% CI, .53–.85]; P < .01) were associated with protection against infection, but anti-HA stalk antibodies were not.

Conclusions

The HA stalk is an independent correlate of protection against A/H3N2 infection, though this association is age dependent. Our results support the continued exploration of the HA stalk as a target for broadly protective influenza vaccines but suggest that the relative benefits may depend on age and influenza virus exposure history.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanInfluenza A Virus, H3N2 SubtypeAntibodies, ViralHemagglutination Inhibition TestsHemagglutinin Glycoproteins, Influenza VirusHumansAdultMaleAdolescentFemaleChildYoung AdultMiddle AgedChild, PreschoolNicaraguaInfantNeuraminidaseAgedFamily CharacteristicsEnzyme-Linked Immunosorbent AssayImmunity, HumoralInfluenza Vaccines

Stichwörter der Autor:innen

correlates of protectionepidemiology of respiratory virusesglobal healthinfluenzavaccination

Substanzen

Antibodies, ViralHemagglutinin Glycoproteins, Influenza VirusNeuraminidaseInfluenza Vaccines

Autor:innen und Institutionen

  • School of Public Health, University of Michigan, Ann Arbor.
  • Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Sustainable Sciences Institute, Managua, Nicaragua.
  • Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Managua, Nicaragua.
  • Centro de Salud Sócrates Flores Vivas, Ministry of Health, Managua, Nicaragua.
  • Center for Vaccine Research and Pandemic Preparedness, Ichan School of Medicine at Mount Sinai, New York, New York.

ORCID-Profile: Gregory Hoy, Florian Krammer, Aubree Gordon

Förderung

  • National Institute of Allergy and Infectious Diseases
  • NIAID NIH HHS
  • University of Michigan
  • NIH HHS
  • Collaborative Influenza Vaccine Innovation Centers
  • St Jude Center of Influenza Research and Surveillance
  • St Jude Center of Excellence for Influenza Research and Response

Zitieren

APA

Hoy, G., Stadlbauer, D., Balmaseda, A., Kuan, G., López, R., Carreno Quiroz, J. M., Ojeda, S., Sánchez, N., Yellin, T., Plazaola, M., Frutos, A., Krammer, F., & Gordon, A. (2024). Humoral Correlates of Protection Against Influenza A/H3N2 Virus Infection. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiae258

Vancouver

Hoy G, Stadlbauer D, Balmaseda A, Kuan G, López R, Carreno Quiroz JM, et al. Humoral Correlates of Protection Against Influenza A/H3N2 Virus Infection. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiae258

BibTeX
@article{Hoy2024,
  author = {Hoy, Gregory and Stadlbauer, Daniel and Balmaseda, Angel and Kuan, Guillermina and López, Roger and Carreno Quiroz, Juan Manuel and Ojeda, Sergio and Sánchez, Nery and Yellin, Temima and Plazaola, Miguel and Frutos, Aaron and Krammer, Florian and Gordon, Aubree},
  title = {Humoral Correlates of Protection Against Influenza A/H3N2 Virus Infection},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiae258}
}
Kostenlos starten →